Pathvanta Partners with KFBIO to Expand Access to Digital Pathology Solutions in Australia

Pathvanta is pleased to announce a strategic partnership with KFBIO, a globally recognised provider of digital pathology technologies. The collaboration marks an important milestone in Pathvanta’s mission to support pathology laboratories across Australia with innovative solutions that enhance diagnostic workflows and laboratory performance.

As healthcare systems continue to embrace digital transformation, pathology laboratories are increasingly seeking technologies that improve efficiency, enable greater collaboration, and support high standards of diagnostic quality. Through this partnership, Pathvanta will bring KFBIO’s comprehensive digital pathology ecosystem to the Australian market, providing laboratories with access to advanced imaging, workflow, and pathology informatics solutions.

KFBIO has built a strong reputation in the field of digital pathology through its commitment to innovation and technology development. Its portfolio spans digital slide scanning, pathology workflow management, laboratory digitisation, and artificial intelligence-enabled applications that support modern pathology practices.

By combining KFBIO’s technology with Pathvanta’s local expertise and customer-focused approach, the partnership aims to help laboratories navigate the transition toward more connected and efficient pathology environments. Australian customers will benefit from local support throughout implementation, validation, training, and ongoing operation, ensuring a practical and sustainable pathway to digital adoption.

Pathvanta stated:
"Digital pathology is becoming an increasingly important part of the future laboratory. We are excited to work alongside KFBIO to make advanced digital pathology technologies more accessible to Australian laboratories. Together, we share a commitment to supporting pathologists and laboratory teams with solutions that improve workflow efficiency, strengthen diagnostic confidence, and contribute to better patient care."

The partnership reflects a shared belief that digital pathology extends beyond the digitisation of slides. It represents a broader opportunity to enhance collaboration, improve access to expertise, support education and research, and create more efficient diagnostic pathways.

Through this collaboration, Australian laboratories will gain access to a range of technologies and services designed to support their digital transformation journey, including digital pathology platforms, workflow management solutions, artificial intelligence applications, and local technical support.

As demand for pathology services continues to grow, Pathvanta remains focused on bringing proven technologies and trusted partnerships to the Australian healthcare sector. Together with KFBIO, the company looks forward to supporting laboratories in delivering high-quality, efficient, and future-ready diagnostic services.